Health Advance Inc. (HADV)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 543.26 Thousand USD | 8.15% |
| 2023 | 502.33 Thousand USD | 78.03% |
| 2022 | 282.17 Thousand USD | 395.5% |
| 2021 | 56.94 Thousand USD | 0.0% |
| 2016 | 159.39 Thousand USD | 22.71% |
| 2015 | 129.89 Thousand USD | 23.31% |
| 2014 | 105.34 Thousand USD | 79.19% |
| 2013 | 58.78 Thousand USD | 67.49% |
| 2012 | 35.09 Thousand USD | 182.6% |
| 2011 | 12.42 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 532.75 Thousand USD | 2.16% |
| 2024 FY | 543.26 Thousand USD | 8.15% |
| 2024 Q3 | 543.26 Thousand USD | 1.97% |
| 2024 Q1 | 521.5 Thousand USD | 3.09% |
| 2023 FY | 502.33 Thousand USD | 78.03% |
| 2023 Q1 | 335.46 Thousand USD | 26.47% |
| 2023 Q4 | 505.84 Thousand USD | 0.7% |
| 2023 Q2 | 471 Thousand USD | 40.4% |
| 2023 Q3 | 502.33 Thousand USD | 6.65% |
| 2022 FY | 282.17 Thousand USD | 395.5% |
| 2022 Q4 | 265.25 Thousand USD | 0.0% |
| 2021 FY | 56.94 Thousand USD | 0.0% |
| 2017 Q1 | 185.33 Thousand USD | 11.54% |
| 2017 Q3 | 283.11 Thousand USD | 0.0% |
| 2016 Q3 | 166.16 Thousand USD | 4.25% |
| 2016 Q2 | 159.39 Thousand USD | 3.16% |
| 2016 Q1 | 154.51 Thousand USD | 4.09% |
| 2016 FY | 159.39 Thousand USD | 22.71% |
| 2016 Q4 | 166.16 Thousand USD | 0.0% |
| 2015 FY | 129.89 Thousand USD | 23.31% |
| 2015 Q4 | 148.44 Thousand USD | 8.88% |
| 2015 Q3 | 136.32 Thousand USD | 4.95% |
| 2015 Q2 | 129.89 Thousand USD | 5.16% |
| 2015 Q1 | 123.51 Thousand USD | 8.98% |
| 2014 Q2 | 105.34 Thousand USD | 20.67% |
| 2014 Q3 | 98.4 Thousand USD | -6.59% |
| 2014 Q1 | 87.29 Thousand USD | 11.3% |
| 2014 FY | 105.34 Thousand USD | 79.19% |
| 2014 Q4 | 113.33 Thousand USD | 15.18% |
| 2013 Q4 | 78.43 Thousand USD | 13.36% |
| 2013 Q3 | 69.19 Thousand USD | 17.7% |
| 2013 Q2 | 58.78 Thousand USD | 32.7% |
| 2013 Q1 | 44.3 Thousand USD | 3.7% |
| 2013 FY | 58.78 Thousand USD | 67.49% |
| 2012 Q4 | 42.72 Thousand USD | 10.5% |
| 2012 Q3 | 38.66 Thousand USD | 10.15% |
| 2012 Q1 | 26.3 Thousand USD | 35.62% |
| 2012 FY | 35.09 Thousand USD | 182.6% |
| 2012 Q2 | 35.09 Thousand USD | 33.42% |
| 2011 Q2 | 12.42 Thousand USD | 0.0% |
| 2011 Q4 | 19.39 Thousand USD | 0.0% |
| 2011 FY | 12.42 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3.15 Million USD | 82.772% |
| Allstar Health Brands, Inc. | 9.3 Million USD | 94.161% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | 98.974% |
| Café Serendipity Holdings, Inc. | 1.31 Million USD | 58.775% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 7.21 Million USD | 92.47% |
| LIGAND PHARMACEUTICAL INC | 86.3 Million USD | 99.371% |
| MedGen, Inc. | 43.63 USD | -1245059.294% |
| Omni Health, Inc. | 1.94 Million USD | 72.02% |
| Oxford Investments Holdings Inc. | 1.01 Million USD | 46.59% |
| Pineapple, Inc. | 10.61 Million USD | 94.883% |
| ScripsAmerica, Inc. | 9.16 Million USD | 94.074% |